{
  "background_dashed": [
    {
      "x": "School-age",
      "y": "Acceptability",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 14.5,
      "Outcome_group": "Safety",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>a small-to-moderate effect in favor of MELAT<\/b> on <u>Acceptability<\/u>. Based on the analysis of the quality of the evidence produced by the 4 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 4
    },
    {
      "x": "School-age",
      "y": "Adverse events",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 14.5,
      "Outcome_group": "Safety",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>no difference between MELAT and controls<\/b> on <u>Adverse events<\/u>. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 2
    },
    {
      "x": "School-age",
      "y": "Tolerability",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 14.5,
      "Outcome_group": "Safety",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>no difference between MELAT and controls<\/b> on <u>Tolerability<\/u>. Based on the analysis of the quality of the evidence produced by the 4 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 4
    },
    {
      "x": "School-age",
      "y": "ADHD symptoms",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 14.5,
      "Outcome_group": "Psych. comorbidity",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>no difference between MELAT and controls<\/b> on <u>ADHD symptoms<\/u>. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 2
    },
    {
      "x": "School-age",
      "y": "Sleep quality",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 14.5,
      "Outcome_group": "Sleep",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>a very strong effect in favor of  MELAT<\/b> on <u>Sleep quality<\/u>. Based on the analysis of the quality of the evidence produced by the 5 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 5
    },
    {
      "x": "School-age",
      "y": "Sleep quantity",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 14.5,
      "Outcome_group": "Sleep",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>a very strong effect in favor of  MELAT<\/b> on <u>Sleep quantity<\/u>. Based on the analysis of the quality of the evidence produced by the 5 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 5
    },
    {
      "x": "School-age",
      "y": "Disruptive behaviors",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 2,
      "pointRadius": 14.5,
      "Outcome_group": "ASD-related symptoms",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>no difference between MELAT and controls<\/b> on <u>Disruptive behaviors<\/u>. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 2
    }
  ],
  "background": [
    {
      "x": "School-age",
      "y": "Acceptability",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 14.5,
      "Outcome_group": "Safety",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>a small-to-moderate effect in favor of MELAT<\/b> on <u>Acceptability<\/u>. Based on the analysis of the quality of the evidence produced by the 4 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 4
    },
    {
      "x": "School-age",
      "y": "Adverse events",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 14.5,
      "Outcome_group": "Safety",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>no difference between MELAT and controls<\/b> on <u>Adverse events<\/u>. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 2
    },
    {
      "x": "School-age",
      "y": "Tolerability",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 14.5,
      "Outcome_group": "Safety",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>no difference between MELAT and controls<\/b> on <u>Tolerability<\/u>. Based on the analysis of the quality of the evidence produced by the 4 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 4
    },
    {
      "x": "School-age",
      "y": "ADHD symptoms",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 14.5,
      "Outcome_group": "Psych. comorbidity",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>no difference between MELAT and controls<\/b> on <u>ADHD symptoms<\/u>. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 2
    },
    {
      "x": "School-age",
      "y": "Sleep quality",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 14.5,
      "Outcome_group": "Sleep",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>a very strong effect in favor of  MELAT<\/b> on <u>Sleep quality<\/u>. Based on the analysis of the quality of the evidence produced by the 5 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 5
    },
    {
      "x": "School-age",
      "y": "Sleep quantity",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 14.5,
      "Outcome_group": "Sleep",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>a very strong effect in favor of  MELAT<\/b> on <u>Sleep quantity<\/u>. Based on the analysis of the quality of the evidence produced by the 5 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 5
    },
    {
      "x": "School-age",
      "y": "Disruptive behaviors",
      "backgroundColor": "rgba(255,255, 255, 0)",
      "borderColor": "#ff8b1a",
      "borderWidth": 0,
      "pointRadius": 14.5,
      "Outcome_group": "ASD-related symptoms",
      "customLabel": "In School-age (6-12 years old)  participants, there is <b>no difference between MELAT and controls<\/b> on <u>Disruptive behaviors<\/u>. Based on the analysis of the quality of the evidence produced by the 2 clinical trials exploring this effect, we have a <b>very low confidence<\/b> in the estimation of this effect.",
      "n_studies": 2
    }
  ],
  "main": [
    {
      "x": "School-age",
      "y": "Acceptability",
      "r": 11,
      "backgroundColor": "#A2CDAE",
      "borderWidth": 0,
      "Outcome_group": "Safety"
    },
    {
      "x": "School-age",
      "y": "Adverse events",
      "r": 8,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Safety"
    },
    {
      "x": "School-age",
      "y": "Tolerability",
      "r": 11,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Safety"
    },
    {
      "x": "School-age",
      "y": "ADHD symptoms",
      "r": 8,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "Psych. comorbidity"
    },
    {
      "x": "School-age",
      "y": "Sleep quality",
      "r": 12.5,
      "backgroundColor": "#30CC5C",
      "borderWidth": 0,
      "Outcome_group": "Sleep"
    },
    {
      "x": "School-age",
      "y": "Sleep quantity",
      "r": 12.5,
      "backgroundColor": "#30CC5C",
      "borderWidth": 0,
      "Outcome_group": "Sleep"
    },
    {
      "x": "School-age",
      "y": "Disruptive behaviors",
      "r": 8,
      "backgroundColor": "#D4D4D4",
      "borderWidth": 0,
      "Outcome_group": "ASD-related symptoms"
    }
  ],
  "star": [
    {
      "x": "School-age",
      "y": "Sleep quality",
      "backgroundColor": "red",
      "borderColor": "#red",
      "r": 17.5,
      "pointRadius": 12.5,
      "Outcome_group": "Sleep"
    },
    {
      "x": "School-age",
      "y": "Sleep quantity",
      "backgroundColor": "red",
      "borderColor": "#red",
      "r": 17.5,
      "pointRadius": 12.5,
      "Outcome_group": "Sleep"
    }
  ],
  "xLabels": ["Pre-school", "School-age", "Adolescents", "Adults"],
  "yLabels": ["Overall ASD symptoms", "Social-communication", "Restricted/repetitive behaviors", "Sensory Profile", "", "Acceptability", "Tolerability", "Adverse events", "", "Global cognition (IQ)", "Adaptive behaviors", "Quality of life", "Language (Overall skills)", "Language (Expressive skills)", "Language (Receptive skills)", "", "ADHD symptoms", "Anxiety", "Mood related symptoms", "", "Disruptive behaviors", "Sleep quality", "Sleep quantity"]
}
